Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes

Abstract Rheumatoid arthritis (RA) is a prevalent autoimmune disorder primarily targeting the diarthrodial joints. During the progression of RA, fibroblast-like synoviocytes (FLSs) exhibit tumor-like behavior, including increased proliferation, inflammation mediation, and aggressive phenotypes, lead...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Zhang, Yang Luo, Hai-Li Shen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-025-05473-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585585244504064
author Li Zhang
Yang Luo
Hai-Li Shen
author_facet Li Zhang
Yang Luo
Hai-Li Shen
author_sort Li Zhang
collection DOAJ
description Abstract Rheumatoid arthritis (RA) is a prevalent autoimmune disorder primarily targeting the diarthrodial joints. During the progression of RA, fibroblast-like synoviocytes (FLSs) exhibit tumor-like behavior, including increased proliferation, inflammation mediation, and aggressive phenotypes, leading to bone erosion. Additionally, T cells in RA acquire pro-inflammatory characteristics, exacerbating the inflammatory environment in affected joints and associated tissues. Notably, senescent T cells contribute to inflammation, further accelerating the disease process. Metabolic changes in rheumatoid FLSs not only maintain their tumor-like properties but also trigger inflammatory cascades, particularly affecting T lymphocytes. This review examines the molecular alterations in RA FLSs in the context of systemic immune aging, with a focus on thymic insufficiency-associated T cell senescence, and explores potential therapeutic avenues.
format Article
id doaj-art-abb296a929034f6babf800e610f000f4
institution Kabale University
issn 1749-799X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-abb296a929034f6babf800e610f000f42025-01-26T12:43:14ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2025-01-0120111010.1186/s13018-025-05473-0Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytesLi Zhang0Yang Luo1Hai-Li Shen2Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou UniversityDepartment of Neurology, The First Hospital of Lanzhou UniversityDepartment of Rheumatology, Lanzhou University Second Hospital, Lanzhou UniversityAbstract Rheumatoid arthritis (RA) is a prevalent autoimmune disorder primarily targeting the diarthrodial joints. During the progression of RA, fibroblast-like synoviocytes (FLSs) exhibit tumor-like behavior, including increased proliferation, inflammation mediation, and aggressive phenotypes, leading to bone erosion. Additionally, T cells in RA acquire pro-inflammatory characteristics, exacerbating the inflammatory environment in affected joints and associated tissues. Notably, senescent T cells contribute to inflammation, further accelerating the disease process. Metabolic changes in rheumatoid FLSs not only maintain their tumor-like properties but also trigger inflammatory cascades, particularly affecting T lymphocytes. This review examines the molecular alterations in RA FLSs in the context of systemic immune aging, with a focus on thymic insufficiency-associated T cell senescence, and explores potential therapeutic avenues.https://doi.org/10.1186/s13018-025-05473-0Fibroblast-like synoviocytesImmunosenescenceMetabolites/cytokinesRheumatoid arthritis
spellingShingle Li Zhang
Yang Luo
Hai-Li Shen
Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
Journal of Orthopaedic Surgery and Research
Fibroblast-like synoviocytes
Immunosenescence
Metabolites/cytokines
Rheumatoid arthritis
title Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
title_full Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
title_fullStr Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
title_full_unstemmed Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
title_short Enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast-like synoviocytes
title_sort enhancing the effectiveness of immunotherapy in rheumatoid arthritis by delaying immunosenescence triggered by fibroblast like synoviocytes
topic Fibroblast-like synoviocytes
Immunosenescence
Metabolites/cytokines
Rheumatoid arthritis
url https://doi.org/10.1186/s13018-025-05473-0
work_keys_str_mv AT lizhang enhancingtheeffectivenessofimmunotherapyinrheumatoidarthritisbydelayingimmunosenescencetriggeredbyfibroblastlikesynoviocytes
AT yangluo enhancingtheeffectivenessofimmunotherapyinrheumatoidarthritisbydelayingimmunosenescencetriggeredbyfibroblastlikesynoviocytes
AT hailishen enhancingtheeffectivenessofimmunotherapyinrheumatoidarthritisbydelayingimmunosenescencetriggeredbyfibroblastlikesynoviocytes